AlphaCrest Capital Management’s NEVRO CORP. NVRO Stock Holding History

AlphaCrest Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,456	Closed	-$394K	–	1195
2022 Q3	$394K	Buy	+8,456	New	+$392K	0.02%	1061
2022 Q2	–	Sell	-6,438	Closed	-$466K	–	1397
2022 Q1	$466K	Sell	6,438 -2,721	-30%	-$196K	0.03%	930
2021 Q4	$743K	Buy	9,159 +5,092	+125%	+$510K	0.03%	930
2021 Q3	$473K	Buy	+4,067	New	+$532K	0.02%	937
2021 Q2	–	Sell	-5,886	Closed	-$821K	–	1365
2021 Q1	$821K	Buy	+5,886	New	+$960K	0.05%	582
2020 Q4	–	Sell	-4,128	Closed	-$575K	–	1302
2020 Q3	$575K	Buy	4,128 +645	+19%	+$86.2K	0.06%	516
2020 Q2	$416K	Buy	3,483 +1,475	+73%	+$175K	0.07%	465
2020 Q1	$201K	Buy	+2,008	New	+$242K	0.02%	940

Other funds holding NVRO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AlphaCrest Capital Management's NVRO Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of NEVRO CORP. (NVRO) in Q4 2022, closing a stake of 8,456 shares — an estimated $394K sold.

AlphaCrest Capital Management first reported a position in NVRO in Q1 2020 and held it in 8 quarters. The position peaked at $821K in Q1 2021. 170 funds tracked by Wall St. Rank hold NVRO as of Q4 2022.

AlphaCrest Capital Management reported no remaining NEVRO CORP. position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 8,456 NEVRO CORP. shares in Q4 2022, an estimated $394K.
AlphaCrest Capital Management first reported a position in NEVRO CORP. in Q1 2020 and held it in 8 quarters.
AlphaCrest Capital Management's NEVRO CORP. position peaked at $821K in Q1 2021.
170 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.